• Explore /
  • Poster
  • / Compliance to chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) according to radiotherapy (RT) dose, overall treatment time (OTT) and chemotherapy (CT) and their impact on long-term outcome: Results of ACT II.

Compliance to chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) according to radiotherapy (RT) dose, overall treatment time (OTT) and chemotherapy (CT) and their impact on long-term outcome: Results of ACT II.

Abstract Poster

Authors

Robert Glynne-Jones

Robert Glynne-Jones

Mount Vernon Centre for Cancer Treatment, London, United Kingdom

Robert Glynne-Jones , Helen Margaret Meadows , Andre Lopes , Richard A. Adams , David Sebag-Montefiore

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Anal Cancer

Clinical Trial Registration Number

26715889

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3518)

DOI

10.1200/jco.2015.33.15_suppl.3518

Abstract #

3518

Poster Bd #

10

Abstract Disclosures

Similar Posters

First Author: Robert Glynne-Jones

First Author: Robert Glynne-Jones

First Author: Cathy Eng

First Author: Marcia Hall